Impax Laboratories (MM) News - IPXLE

By Jonathan D. Rockoff The maker of an EpiPen rival said its emergency allergy treatment would return to the market on Feb. 14, adding more...

By Jonathan D. Rockoff The maker of an EpiPen rival said its emergency allergy treatment would return to the market on Feb. 14, adding more...

By Anne Steele and Joseph Walker A top U.S. health insurer has dropped its coverage of Mylan NV's brand-name EpiPen and switched to the...

A Justice Department probe of possible price collusion by generic drug companies could lead to criminal charges by the end of the year, Bloomberg...

Teva Pharmaceutical Industries Ltd. is based in Israel. "Teva, Allergan Get FTC Approval for Generics Purchase," at 3:21 p.m. ET as well...

Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan...

By Lisa Beilfuss Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of...

Teva Pharmaceutical Industries Ltd., which is working toward a $40.5 billion acquisition of Allergan PLC's generics unit, increased its...

Canadian Pacific Railway Railroad Warns On Weaker Results Canadian Pacific Railway Ltd. warned on Tuesday its second-quarter results would take a...

Impax Laboratories Inc. said Tuesday that it would buy a portfolio of generic drugs from Israel's Teva Pharmaceutical Industries Ltd. and...

By Austen Hufford Impax Laboratories Inc. said Tuesday that it would buy a portfolio of generic drugs from Israel's Teva Pharmaceutical...

The Federal Trade Commission filed a lawsuit against Endo International PLC and other drugmakers, alleging Endo paid others to delay releases of...

A small pharmaceutical company that has come under fire for a more than 50-fold hike in the price of a drug used to fight a parasitic infection...

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that it has received notification from The Nasdaq Stock Market, Inc. that the Nasdaq...